We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Beximco

News List

Beximco Pharma to manufacture molnupiravir for COVID-19 pharmatimes
January 20, 2022
The drug received conditional marketing authorisation in the UK from the MHRA in November
Bangladesh signs Covid-19 vaccine deal with Serum Institute of India pharmaceutical-technology
November 09, 2020
Bangladesh has entered into a deal with the Serum Institute of India (SII) to acquire 30 million doses of a potential vaccine being developed by AstraZeneca for Covid-19.
Beximco signs deal with Serum Institute of India for COVID-19 vaccines expresspharma
August 31, 2020
Beximco Pharmaceuticals from Bangladesh announced investment in the Serum Institute of India (SII) for priority access to COVID-19 vaccines being developed by the Indian pharma manufacturer.